BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 26970307)

  • 21. Casticin Induced Apoptosis in A375.S2 Human Melanoma Cells through the Inhibition of NF-[Formula: see text]B and Mitochondria-Dependent Pathways In Vitro and Inhibited Human Melanoma Xenografts in a Mouse Model In Vivo.
    Shiue YW; Lu CC; Hsiao YP; Liao CL; Lin JP; Lai KC; Yu CC; Huang YP; Ho HC; Chung JG
    Am J Chin Med; 2016; 44(3):637-61. PubMed ID: 27109154
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synergistic interactions between sorafenib and bortezomib in hepatocellular carcinoma involve PP2A-dependent Akt inactivation.
    Chen KF; Yu HC; Liu TH; Lee SS; Chen PJ; Cheng AL
    J Hepatol; 2010 Jan; 52(1):88-95. PubMed ID: 19913321
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Short-chain C6 ceramide sensitizes AT406-induced anti-pancreatic cancer cell activity.
    Zhao X; Sun B; Zhang J; Zhang R; Zhang Q
    Biochem Biophys Res Commun; 2016 Oct; 479(2):166-172. PubMed ID: 27562715
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting sphingosine kinase 2 by ABC294640 inhibits human skin squamous cell carcinoma cell growth.
    Zhou J; Chen J; Yu H
    Biochem Biophys Res Commun; 2018 Mar; 497(2):535-542. PubMed ID: 29428730
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bufadienolides induce apoptosis and autophagy by inhibiting the AKT signaling pathway in melanoma A‑375 cells.
    Li H; Cao X; Chen X; Yi X; Xia J; Chen J; Yang L
    Mol Med Rep; 2019 Sep; 20(3):2347-2354. PubMed ID: 31322190
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms of Tanshinone II a inhibits malignant melanoma development through blocking autophagy signal transduction in A375 cell.
    Li X; Li Z; Li X; Liu B; Liu Z
    BMC Cancer; 2017 May; 17(1):357. PubMed ID: 28532456
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Propranolol induced G0/G1/S phase arrest and apoptosis in melanoma cells via AKT/MAPK pathway.
    Zhou C; Chen X; Zeng W; Peng C; Huang G; Li X; Ouyang Z; Luo Y; Xu X; Xu B; Wang W; He R; Zhang X; Zhang L; Liu J; Knepper TC; He Y; McLeod HL
    Oncotarget; 2016 Oct; 7(42):68314-68327. PubMed ID: 27582542
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oxyfadichalcone C inhibits melanoma A375 cell proliferation and metastasis via suppressing PI3K/Akt and MAPK/ERK pathways.
    Peng X; Wang Z; Liu Y; Peng X; Liu Y; Zhu S; Zhang Z; Qiu Y; Jin M; Wang R; Zhang Q; Kong D
    Life Sci; 2018 Aug; 206():35-44. PubMed ID: 29782872
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chaetocin induces apoptosis in human melanoma cells through the generation of reactive oxygen species and the intrinsic mitochondrial pathway, and exerts its anti-tumor activity in vivo.
    Han X; Han Y; Zheng Y; Sun Q; Ma T; Zhang J; Xu L
    PLoS One; 2017; 12(4):e0175950. PubMed ID: 28419143
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DC120, a novel and potent inhibitor of AKT kinase, induces tumor cell apoptosis and suppresses tumor growth.
    Deng R; Yang F; Chang SH; Tang J; Qin J; Feng GK; Ding K; Zhu XF
    Mol Pharmacol; 2012 Aug; 82(2):189-98. PubMed ID: 22553359
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 1-phenyl-2-decanoylamino-3-morpholino-1-propanol (PDMP) facilitates curcumin-induced melanoma cell apoptosis by enhancing ceramide accumulation, JNK activation, and inhibiting PI3K/AKT activation.
    Yu T; Li J; Qiu Y; Sun H
    Mol Cell Biochem; 2012 Feb; 361(1-2):47-54. PubMed ID: 21959977
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ferulic Acid Exerts Anti-Angiogenic and Anti-Tumor Activity by Targeting Fibroblast Growth Factor Receptor 1-Mediated Angiogenesis.
    Yang GW; Jiang JS; Lu WQ
    Int J Mol Sci; 2015 Oct; 16(10):24011-31. PubMed ID: 26473837
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Esculetin exerts antitumor effect on human gastric cancer cells through IGF-1/PI3K/Akt signaling pathway.
    Wang G; Lu M; Yao Y; Wang J; Li J
    Eur J Pharmacol; 2017 Nov; 814():207-215. PubMed ID: 28847482
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PI3K Pathway Inhibition Achieves Potent Antitumor Activity in Melanoma Brain Metastases In Vitro and In Vivo.
    Niessner H; Schmitz J; Tabatabai G; Schmid AM; Calaminus C; Sinnberg T; Weide B; Eigentler TK; Garbe C; Schittek B; Quintanilla-Fend L; Bender B; Mai M; Praetorius C; Beissert S; Schackert G; Muders MH; Meinhardt M; Baretton GB; Dummer R; Flaherty K; Pichler BJ; Kulms D; Westphal D; Meier F
    Clin Cancer Res; 2016 Dec; 22(23):5818-5828. PubMed ID: 27307593
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design, synthesis, and identification of a novel napthalamide-isoselenocyanate compound NISC-6 as a dual Topoisomerase-IIα and Akt pathway inhibitor, and evaluation of its anti-melanoma activity.
    Karelia DN; Sk UH; Singh P; Gowda ASP; Pandey MK; Ramisetti SR; Amin S; Sharma AK
    Eur J Med Chem; 2017 Jul; 135():282-295. PubMed ID: 28458134
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Licochalcone D induces apoptosis and inhibits migration and invasion in human melanoma A375 cells.
    Si L; Yan X; Hao W; Ma X; Ren H; Ren B; Li D; Dong Z; Zheng Q
    Oncol Rep; 2018 May; 39(5):2160-2170. PubMed ID: 29565458
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The novel HDAC inhibitor AR-42-induced anti-colon cancer cell activity is associated with ceramide production.
    Xu W; Xu B; Yao Y; Yu X; Shen J
    Biochem Biophys Res Commun; 2015 Aug; 463(4):545-50. PubMed ID: 26026677
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Versatile antitumor potential of isoxanthohumol: Enhancement of paclitaxel activity in vivo.
    Krajnović T; Kaluđerović GN; Wessjohann LA; Mijatović S; Maksimović-Ivanić D
    Pharmacol Res; 2016 Mar; 105():62-73. PubMed ID: 26784390
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A DC-81-indole conjugate agent suppresses melanoma A375 cell migration partially via interrupting VEGF production and stromal cell-derived factor-1α-mediated signaling.
    Hsieh MC; Hu WP; Yu HS; Wu WC; Chang LS; Kao YH; Wang JJ
    Toxicol Appl Pharmacol; 2011 Sep; 255(2):150-9. PubMed ID: 21708181
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Small molecule inhibition of polo-like kinase 1 by volasertib (BI 6727) causes significant melanoma growth delay and regression in vivo.
    Cholewa BD; Ndiaye MA; Huang W; Liu X; Ahmad N
    Cancer Lett; 2017 Jan; 385():179-187. PubMed ID: 27793694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.